当前位置：药药网 / 药品 / 美国NDC复合药物数据库文件(本栏目收费,不能显示细节,电话13136136841)
药品名称： 商品名称： 药品NDC： 报告期内： -格式:2020-5-3
NDC包装id： 市场分类： 活性成分： 持证企业：
 美国NDC复合药物数据库文件1279条(本栏目收费,不能显示细节,电话13136136841)
药品名称(分析)
商品名
药品NDC
专利人(分析)
报告期内
活性成分
市场分类
规格(分析)
NDC包装id
Norepinephrine Bitartrate
HUMAN COMPOUNDED DRUG
73702-115
Wells Pharma of Houston
2021/2/1 0:00:00
NOREPINEPHRINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
8 mg/250 mL
73702-115-03
Norepinephrine Bitartrate
HUMAN COMPOUNDED DRUG
73702-119
Wells Pharma of Houston
2021/2/1 0:00:00
NOREPINEPHRINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
16 mg/250 mL
73702-119-03
Norepinephrine Bitartrate
HUMAN COMPOUNDED DRUG
73702-114
Wells Pharma of Houston
2021/2/1 0:00:00
NOREPINEPHRINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 mg/250 mL
73702-114-03
Succinylcholine Chloride
HUMAN COMPOUNDED DRUG
73702-134
Wells Pharma of Houston
2021/2/1 0:00:00
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
73702-134-10
Succinylcholine Chloride
HUMAN COMPOUNDED DRUG
73702-134
Wells Pharma of Houston
2021/2/1 0:00:00
SUCCINYLCHOLINE CHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
73702-134-15
Ropivacaine HCl
HUMAN COMPOUNDED DRUG
73702-135
Wells Pharma of Houston
2021/2/1 0:00:00
ROPIVACAINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 mg/1 mL
73702-135-80
Norepinephrine Bitartrate
HUMAN COMPOUNDED DRUG
73702-116
Wells Pharma of Houston
2021/2/1 0:00:00
NOREPINEPHRINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
16 mg/250 mL
73702-116-03
Norepinephrine Bitartrate
HUMAN COMPOUNDED DRUG
73702-117
Wells Pharma of Houston
2021/2/1 0:00:00
NOREPINEPHRINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
4 mg/250 mL
73702-117-03
Trophamine 3.5% / Dextrose 10% With Calcium Gluconate 3.75 mEq 250ml in 250ml bag
HUMAN COMPOUNDED DRUG
72196-0407
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
CALCIUM GLUCONATE MONOHYDRATE; LYSINE ACETATE; SERINE; TYROSINE; N-ACETYLTYROSINE; THREONINE; CYSTEINE HYDROCHLORIDE; HISTIDINE; ARGININE; TAURINE; DEXTROSE MONOHYDRATE; LEUCINE; METHIONINE; GLUTAMIC ACID; PROLINE; ASPARTIC ACID; ISOLEUCINE; ALANINE; GLYCINE; PHENYLALANINE; TRYPTOPHAN; VALINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
3.75 meq/250 mL; 1.05 g/250 mL; .3325 g/250 mL; .0385 g/250 mL; .21 g/250 mL; .3675 g/250 mL; .021 g/250 mL; .42 g/250 mL; 1.05 g/250 mL; .021875 g/250 mL; 25 g/250 mL; 1.225 g/250 mL; .2975 g/250 mL; .4375 g/250 mL; .595 g/250 mL; .28 g/250 mL; .7175 g/250 mL; .4725 g/250 mL; .315 g/250 mL; .42 g/250 mL; .175 g/250 mL; .6825 g/250 mL
72196-0407-1
Vancomycin 1gm added to NS
HUMAN COMPOUNDED DRUG
72196-6064
Central Admixture Pharmacy Services, Inc.
2021/2/1 0:00:00
VANCOMYCIN HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
1 g/250 mL
72196-6064-1
Norepinephrine Bitartrate
HUMAN COMPOUNDED DRUG
73702-118
Wells Pharma of Houston
2021/2/1 0:00:00
NOREPINEPHRINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
8 mg/250 mL
73702-118-03
Cefazolin Sodium
HUMAN COMPOUNDED DRUG
73702-132
Wells Pharma of Houston
2021/2/1 0:00:00
CEFAZOLIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 g/1 mL
73702-132-23
Cefazolin Sodium
HUMAN COMPOUNDED DRUG
73702-132
Wells Pharma of Houston
2021/2/1 0:00:00
CEFAZOLIN
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
.2 g/1 mL
73702-132-10
Fentanyl Citrate
HUMAN COMPOUNDED DRUG
73702-202
Wells Pharma of Houston
2021/2/1 0:00:00
FENTANYL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 ug/1 mL
73702-202-03
Fentanyl Citrate
HUMAN COMPOUNDED DRUG
73702-202
Wells Pharma of Houston
2021/2/1 0:00:00
FENTANYL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 ug/1 mL
73702-202-02
Fentanyl Citrate
HUMAN COMPOUNDED DRUG
73702-202
Wells Pharma of Houston
2021/2/1 0:00:00
FENTANYL
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
10 ug/1 mL
73702-202-15
Lidocaine HCl
HUMAN COMPOUNDED DRUG
73702-111
Wells Pharma of Houston
2021/2/1 0:00:00
LIDOCAINE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
20 mg/1 mL
73702-111-15
Phenylephrine HCl
HUMAN COMPOUNDED DRUG
73702-123
Wells Pharma of Houston
2021/2/1 0:00:00
PHENYLEPHRINE HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
40 ug/1 mL
73702-123-10
Midazolam HCl 100 mg/100 mL
HUMAN COMPOUNDED DRUG
51754-9131
Exela Pharma Sciences, LLC.
2021/2/1 0:00:00
MIDAZOLAM HYDROCHLORIDE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
100 mg/100 mL
51754-9131-5
Fentanyl Citrate Injection 5000 mcg/100 mL
HUMAN COMPOUNDED DRUG
51754-9160
Exela Pharma Sciences, LLC.
2021/2/1 0:00:00
FENTANYL CITRATE
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
5000 ug/100 mL
51754-9160-1
网站地图 - 网站开发 - 网站简介 - 会员服务 - 法律声明 - 联系我们 - 药品招商频道 - 药品信息排行 - 2018年版国家基本药物目录 - 意见反馈
免责声明：以上所展示的信息由企业自行提供，内容的真实性、准确性和合法性由发布企业负责，医药网对此不承担任何责任。
相关链接：医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究　　客服热线：0575-83552251 / 13754370441  QQ客服：药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证：浙B2-20220931　互联网药品信息服务资格证书编号：(浙)-经营性2023-0215　浙公网安备:330683240604819103159
　医药代理商群１：药药网药品采购交流医药代理商群２：药药网药品采购交流2医药代理商群３：药药网药品采购交流3